PharVision Advisers’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$255K Sell
2,373
-1,436
-38% -$154K 0.37% 129
2025
Q1
$384K Buy
+3,809
New +$384K 0.53% 41